Lethal bite
Malaria is the 5th responsible cause of death from infectious disease worldwide, and approximately half the global population are at risk. 1A team of scientists in Missouri, USA3 has recently answered a long-standing question regarding the metabolism of the parasite, advancing research towards identifying novel therapeutics
Malaria is the 5th biggest killer worldwide and approximately half the global population are at risk1. The causativeagent of malaria, the parasite Plasmodiumfalciparum, is transmitted via the bite of aninfected Anopheles mosquito. Followingtransmission, the parasite is transportedvia the blood stream to the liver whereit multiplies and subsequently infects redblood cells (RBC’s) at the so-called bloodinfection stage2.
A team of scientists in Missouri, USA,3 hasrecently answered a long-standing questionregarding the metabolism of the parasite,advancing research towards identifyingnovel therapeutic targets.
To analyse the reaction products resultingfrom in vitro parasitic heme degradationpathways, a range of chromatographictechniques were used. HPLC (highperformance liquid chromatography)coupled to high resolution massspectrometry was used for the analysis ofreaction products generated during in vitroheme degradation; and both affinity andsize-exclusion chromatography were usedfor protein purification.
The leading author of the study, PaulSigala, told The Column: “Human infectionby Plasmodium falciparum parasites, thecausative agent of malaria, remains asevere public health problem worldwideand a better understanding of parasitemetabolism can clarify what are or are notappropriate therapeutic targets. Duringthe blood-infection stage, the parasitemust deal with a vast amount of heme,most of which is derived from digestion ofthe hemoglobin within red blood cells. Ithas remained unclear whether a portionof this heme is enzymatically processed byparasites for utilization or disposal. Ourstudy thus clarifies a fundamental aspectof parasite biology, which will focus effortson remaining pathways that are operativewithin parasites.”
It is hoped that these findings willadvance the understanding of malariacausing parasite transmission, furtheradvancing progress towards theidentification of valid therapeutic targets.
1. Centre for Disease Control, www.cdc.gov/malaria/about/facts.html (Accessed24th of September 2012).
2. World Health Organization: www.who.int/topics/malaria/en/ (Accessed 24th ofSeptember 2012).
3. Paul A. Sigala et al., The Journalof Biological Chemistry, DOI:10.1074/jbc.M112.414078(2012).
This story originally appeared in The Column. Click here to view that issue.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
